A5101551831- Neutropenia and Cancer Infections
- Bacterial Identification and Susceptibility Testing
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Resistance in Bacteria
- Mycobacterium research and diagnosis
- Clostridium difficile and Clostridium perfringens research
Hospital Italiano de Buenos Aires
2024-2025
Few studies have evaluated the efficacy of ceftazidime–avibactam (CA) for Klebsiella pneumoniae carbapenemase-producing Enterobacterales bacteremia (KPC-PEB) in high-risk neutropenic patients. This is a prospective multicenter observational study patients with multi-drug resistant bacteremia. They were compared according to resistance mechanism and definitive treatment provided: KPC-CPE treated CA (G1), other antibiotics (G2), ESBL-producing who received appropriate therapy (G3). Thirty-day...
Abstract Background The epidemiology of bacteremia (B) in neutropenic patients (NP) may differ according to the geographic region or country and can change over time. growing rate multidrug-resistant gram-negative bacilli (MDR-GNB) is usually associated with higher mortality. Methods Prospective multicenter study. All first episodes B adult NP hematologic malignancies were included 9 centers Argentina, from May 2014 December 2023. They divided three periods: 2014-June 2017 (P1), July...